Retrospective study of hepatic enzyme elevations in children treated with olanzapine, divalproex, and their combination

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 42, Issue 10, 2003, Pages 1227-1233

  Gonzalez Heydrich, Joseph ^{a,c,d,e,f,g,h,i,j,k,l}   Raches, Darcy ^a   Wilens, Timothy E ^b   Leichtner, Alan ^a   Mezzacappa, Enrico ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ABBOTT LABORATORIES   (United States)

^d JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^e PFIZER INC   (United States)

^f Akzo Nobel Organon   (United States)

^g GLAXOSMITHKLINE   (United States)

^h Shire   (United States)

ⁱ Alza   (United States)

^j Cephalon   (United States)

^k Eli Lily   (United States)

^l NOVARTIS   (Switzerland)

more..

Author keywords

Divalproex; Hepatic function; Olanzapine; Pancreatitis; Polypharmacy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; LACTATE DEHYDROGENASE; OLANZAPINE; VALPROATE SEMISODIUM; ASPARTATE AMINOTRANSFERASE; BENZODIAZEPINE DERIVATIVE; DRUG DERIVATIVE; NEUROLEPTIC AGENT; PIRENZEPINE; TRANQUILIZER; VALPROIC ACID;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BIPOLAR DISORDER; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DRUG WITHDRAWAL; ENZYME ACTIVATION; FATTY LIVER; HUMAN; INFORMATION PROCESSING; INFORMATION RETRIEVAL; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MEDICAL RECORD; PANCREATITIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG INTERACTION; ENZYMOLOGY; FEMALE; LIVER; MALE; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; ALANINE TRANSAMINASE; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; ASPARTATE AMINOTRANSFERASES; BENZODIAZEPINES; CHILD; CHILD, PRESCHOOL; DRUG INTERACTIONS; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LIVER; MALE; PANCREATITIS; PIRENZEPINE; RETROSPECTIVE STUDIES; VALPROIC ACID;

EID: 0142227987     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200310000-00014     Document Type: Article

References (27)

1. Abbott (2002), Depakote (divalproex sodium) tablets. In: Physicians' Desk Reference, 56th ed. Montvale, NJ: Medical Economics Company, pp 430-437
2. Anderson MC (1966), Hepatic morphology and function: alterations associated with acute pancreatitis. Arch Surg 92:664-671
3. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, Higgins L, Lavine JE (1995), Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 127:700-704
4. Beasley CM Jr, Tollefson GD, Tran PV (1997), Safety of olanzapine. J Clin Psychiatry 58:13-17
5. Butler ML (1973), Abnormalities of liver function in acute pancreatitis. South Med Assoc J 66:700-702
6. Cadario B (2000), Olanzapine (Zyprexa): suspected serious reactions. Can Med Assoc J 163:85-90
7. Casey DE, Daniel D, Tracy K, Wozniak P, Sommerville K (2001), Improved antipsychotic effect of divalproex combined with risperidone or olanzapine for schizophrenia. In: World Assembly of Mental Health, 26th Biennial Congress of the World Federation for Mental Health, Vancouver, BC, Canada. Available from Dr. Daniel Casey (daniel.casey@med.va.gov)
8. Chang KD, Ketter TA (2001), Special issues in the treatment of paediatric bipolar disorder. Exp Op Pharmacotherapy 2:613-622
9. Chapman SA, Wacksman GP, Patterson BD (2001), Pancreatitis associated with valproic acid: a review of the literature. Pharmacotherapy 21:1549-1560
10. Chittun S, George J (2002), Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs. Semin Liver Dis 22:169-183
11. Frazier JA, Biederman J, Tohen M et al. (2001), A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 11:239-250
12. Glauser TA (2000), Idiosyncratic reactions: new methods of identifying high-risk patients. Epilepsia 41:S16-S29
13. Hagger R, Brown C, Hurley P (2000), Olanzapine and pancreatitis. Br J Psychiatry 177:567
14. Klee S, Johanssen S, Ungemach FR (2000), Evidence for a trigger function of valproic acid in xenobiotic-induced hcpacotoxicity. Pharmacol Toxicol 87:89-95
15. Kumra S, Jacobsen LK, Lenane M, Karp BI et al. (1998), Childhood-onset schizophrenia: an open-label study of olanzapine in adolescents. J Am Acad Child Adolesc Psychiatry 37:377-385
16. Lilly (2002), Zyprexa (olanzapine) tablets. In: Physicians' Desk Reference, 56th ed. Montvale, NJ: Medical Economics Company, pp 1973-1978
17. Moran JR, Ghishan FK, Halter SA, Greene HL (1983), Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol 78:374-377
18. Nemeroff CB (1997), Dosing the antipsychotic medication olanzapine. J Clin Psychiatry 58:45-49
19. Pellock JM, Wilder BJ, Deaton R, Sommerville KW (2002), Acute pancreatitis coincident with valproate use: a critical review. Epilepsia 43:1421-1424
20. Potenza MN, Holmes JP, Kanes SJ, McDougle CJ (1999), Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study. J Clin Psychopharmacol 19:37-44
21. Prior TI, Chue PS, Tibbo P, Baker GB (1999), Drug metabolism and atypical antipsychotics. Eur Neuropsychopharmacol 9:301-309
22. Ragucci KR, Wells BJ (2001), Olanzapine-induced diabetic ketoacidosis. Ann Pharmacother 35:1556-1558
23. Rettie AE, Rettenmeier AW, Howald WN, Baillie TA (1987), Cytochrome P-450-catalyzed formation of delta 4-VTA, a toxic metabolite of valproic acid. Science 235:890-893
24. Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, De Vincenzo A (1994), Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 125:239-241
25. Woods SW, Martin A, Spector SG, McGlashan TH (2002), Effects of development on olanzapine-associated adverse events. J Am Acad Child Adolesc Psychiatry 41:1439-1446
26. Wyllie E, Wyllie R (1991), Routine laboratory monitoring for serious adverse effects of antiepileptic medications: the controversy. Epilepsia 32:S74-S79
27. Yazdani K, Lippmann M, Gala I (2002), Fatal pancreatitis associated with valproic acid: review of the literature. Medicine 81:305-310